Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $1,895 | 1 | 43.5% |
| Travel and Lodging | $1,236 | 3 | 28.4% |
| Food and Beverage | $1,224 | 32 | 28.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $1,927 | 4 | $0 (2019) |
| Great Lakes Orthopedics | $1,295 | 4 | $0 (2019) |
| Trice Medical, Inc. | $607.69 | 1 | $0 (2018) |
| IBSA Pharma Inc. | $205.24 | 15 | $0 (2024) |
| Smith+Nephew, Inc. | $146.40 | 1 | $0 (2019) |
| Flexion Therapeutics, Inc. | $60.44 | 4 | $0 (2020) |
| Electronic Waveform Lab, Inc. | $35.59 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $32.17 | 2 | $0 (2020) |
| Bioventus LLC | $16.33 | 1 | $0 (2022) |
| Pacira Pharmaceuticals Incorporated | $15.43 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.44 | 3 | IBSA Pharma Inc. ($30.88) |
| 2023 | $30.79 | 2 | IBSA Pharma Inc. ($30.79) |
| 2022 | $47.37 | 3 | IBSA Pharma Inc. ($31.04) |
| 2021 | $127.96 | 10 | IBSA Pharma Inc. ($112.53) |
| 2020 | $92.96 | 6 | Flexion Therapeutics, Inc. ($49.21) |
| 2019 | $3,392 | 10 | Arthrex, Inc. ($1,927) |
| 2018 | $618.92 | 2 | Trice Medical, Inc. ($607.69) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Endocrinology | ||||||
| 02/27/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Sports Early Intervention | ||||||
| 02/09/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| Category: Endocrinology | ||||||
| 12/12/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: non-opioid analgesic | ||||||
| 10/31/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: non-opioid analgesic | ||||||
| 06/13/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Endocrinology | ||||||
| 03/08/2022 | Bioventus LLC | Supartz FX Sodium Hyaluronate (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Not Applicable | ||||||
| 01/06/2022 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: non-opioid analgesic | ||||||
| 08/02/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: non-opioid analgesic | ||||||
| 07/01/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: non-opioid analgesic | ||||||
| 06/09/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: non-opioid analgesic | ||||||
| 05/12/2021 | Pacira Pharmaceuticals Incorporated | Iovera System (Device) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Pain Management | ||||||
| 05/06/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: non-opioid analgesic | ||||||
| 04/21/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $5.29 | General |
| Category: non-opioid analgesic | ||||||
| 04/07/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $9.64 | General |
| Category: non-opioid analgesic | ||||||
| 03/30/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: non-opioid analgesic | ||||||
| 03/23/2021 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | Cash or cash equivalent | $5.69 | General |
| Category: non-opioid analgesic | ||||||
| 03/10/2021 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Endocrinology | ||||||
| 12/14/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Musculoskeletal | ||||||
| 11/05/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Musculoskeletal | ||||||
| 09/02/2020 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 07/16/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Musculoskeletal | ||||||
| 06/25/2020 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 03/12/2020 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.58 | General |
| 05/01/2019 | Smith+Nephew, Inc. | Regeneten (Device) | Food and Beverage | In-kind items and services | $146.40 | General |
| Category: Sports Med Shoulder | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 147 | 407 | $75,877 | $16,696 |
| 2022 | 6 | 119 | 301 | $43,459 | $9,834 |
| 2021 | 7 | 111 | 299 | $38,472 | $9,331 |
| 2020 | 3 | 46 | 58 | $11,971 | $1,716 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 26 | 84 | $37,136 | $4,999 | 13.5% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 13 | 64 | $7,680 | $3,674 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 45 | $9,727 | $2,748 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,577 | $2,112 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $7,198 | $1,666 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 16 | $5,072 | $1,383 | 27.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 157 | $486.70 | $113.80 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 47 | $10,159 | $3,001 | 29.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 12 | 30 | $13,263 | $2,303 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $9,076 | $1,934 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 19 | $6,023 | $1,606 | 26.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 15 | 20 | $4,455 | $853.52 | 19.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 156 | $483.60 | $136.84 | 28.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 40 | $8,646 | $2,589 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 18 | $5,706 | $1,788 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $5,718 | $1,537 | 26.9% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 11 | 19 | $8,400 | $1,390 | 16.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $5,007 | $1,044 | 20.9% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 16 | 20 | $4,455 | $824.81 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 18 | 174 | $539.40 | $156.97 | 29.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 29 | $4,399 | $852.28 | 19.4% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 13 | 15 | $3,643 | $475.65 | 13.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 12 | 14 | $3,929 | $387.89 | 9.9% |
About Dr. Marjorie Delo, MD
Dr. Marjorie Delo, MD is a Family Medicine healthcare provider based in Green Bay, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356424691.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marjorie Delo, MD has received a total of $4,355 in payments from pharmaceutical and medical device companies, with $45.44 received in 2024. These payments were reported across 36 transactions from 11 companies. The most common payment nature is "Education" ($1,895).
As a Medicare-enrolled provider, Delo has provided services to 423 Medicare beneficiaries, totaling 1,065 services with total Medicare billing of $37,576. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Sports Medicine
- Location Green Bay, WI
- Active Since 10/23/2006
- Last Updated 12/09/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356424691
Products in Payments
- mi-eye (Device) $607.69
- Regeneten (Device) $146.40
- Licart (Drug) $108.05
- Tirosint (Drug) $66.40
- Zilretta (Drug) $60.44
- SYNVISC-ONE (Device) $32.17
- LICART (Drug) $30.79
- Supartz FX Sodium Hyaluronate (Device) $16.33
- Iovera System (Device) $15.43
- ORTHOVISC (Device) $14.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Green Bay
Mark Jenson, M.d, M.D
Family Medicine — Payments: $211,802
Stephen Hathway, Md, MD
Family Medicine — Payments: $110,565
Dr. Lisa Allen, M.d, M.D
Family Medicine — Payments: $23,625
Matthew Jenson, Md, MD
Family Medicine — Payments: $10,257
Daniel Lemkuil, Md, MD
Family Medicine — Payments: $4,271
Melissa Hidde, Md, MD
Family Medicine — Payments: $3,625